Cargando…

Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment

Chinese herbal medicines (CHMs) are widely used in China and have long been a powerful method to treat diseases in Chinese people. Bioactive ingredients are the main components extracted from herbs that have therapeutic properties. Since artemisinin was discovered to inhibit malaria by Nobel laureat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yan, Chen, Hengwen, Gao, Jialiang, Liu, Yongmei, Li, Jun, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537929/
https://www.ncbi.nlm.nih.gov/pubmed/31178721
http://dx.doi.org/10.3389/fphar.2019.00515
_version_ 1783422097863737344
author Dong, Yan
Chen, Hengwen
Gao, Jialiang
Liu, Yongmei
Li, Jun
Wang, Jie
author_facet Dong, Yan
Chen, Hengwen
Gao, Jialiang
Liu, Yongmei
Li, Jun
Wang, Jie
author_sort Dong, Yan
collection PubMed
description Chinese herbal medicines (CHMs) are widely used in China and have long been a powerful method to treat diseases in Chinese people. Bioactive ingredients are the main components extracted from herbs that have therapeutic properties. Since artemisinin was discovered to inhibit malaria by Nobel laureate Youyou Tu, extracts from natural plants, particularly bioactive ingredients, have aroused increasing attention among medical researchers. The bioactive ingredients of some CHMs have been found to target various non-coding RNA molecules (ncRNAs), especially miRNAs, lncRNAs, and circRNAs, which have emerged as new treatment targets in numerous diseases. Here we review the evidence that, by regulating the expression of ncRNAs, these ingredients exert protective effects, including pro-apoptosis, anti-proliferation and anti-migration, anti-inflammation, anti-atherosclerosis, anti-infection, anti-senescence, and suppression of structural remodeling. Consequently, they have potential as treatment agents in diseases such as cancer, cardiovascular disease, nervous system disease, inflammatory bowel disease, asthma, infectious diseases, and senescence-related diseases. Although research has been relatively limited and inadequate to date, the promising choices and new alternatives offered by bioactive ingredients for the treatment of the above diseases warrant serious investigation.
format Online
Article
Text
id pubmed-6537929
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65379292019-06-07 Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment Dong, Yan Chen, Hengwen Gao, Jialiang Liu, Yongmei Li, Jun Wang, Jie Front Pharmacol Pharmacology Chinese herbal medicines (CHMs) are widely used in China and have long been a powerful method to treat diseases in Chinese people. Bioactive ingredients are the main components extracted from herbs that have therapeutic properties. Since artemisinin was discovered to inhibit malaria by Nobel laureate Youyou Tu, extracts from natural plants, particularly bioactive ingredients, have aroused increasing attention among medical researchers. The bioactive ingredients of some CHMs have been found to target various non-coding RNA molecules (ncRNAs), especially miRNAs, lncRNAs, and circRNAs, which have emerged as new treatment targets in numerous diseases. Here we review the evidence that, by regulating the expression of ncRNAs, these ingredients exert protective effects, including pro-apoptosis, anti-proliferation and anti-migration, anti-inflammation, anti-atherosclerosis, anti-infection, anti-senescence, and suppression of structural remodeling. Consequently, they have potential as treatment agents in diseases such as cancer, cardiovascular disease, nervous system disease, inflammatory bowel disease, asthma, infectious diseases, and senescence-related diseases. Although research has been relatively limited and inadequate to date, the promising choices and new alternatives offered by bioactive ingredients for the treatment of the above diseases warrant serious investigation. Frontiers Media S.A. 2019-05-21 /pmc/articles/PMC6537929/ /pubmed/31178721 http://dx.doi.org/10.3389/fphar.2019.00515 Text en Copyright © 2019 Dong, Chen, Gao, Liu, Li and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Dong, Yan
Chen, Hengwen
Gao, Jialiang
Liu, Yongmei
Li, Jun
Wang, Jie
Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
title Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
title_full Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
title_fullStr Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
title_full_unstemmed Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
title_short Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
title_sort bioactive ingredients in chinese herbal medicines that target non-coding rnas: promising new choices for disease treatment
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537929/
https://www.ncbi.nlm.nih.gov/pubmed/31178721
http://dx.doi.org/10.3389/fphar.2019.00515
work_keys_str_mv AT dongyan bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment
AT chenhengwen bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment
AT gaojialiang bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment
AT liuyongmei bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment
AT lijun bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment
AT wangjie bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment